Silver Diamine Fluoride: Can It Stop Children's

What did the trial find about stopping childhood cavities?

The study, published in JAMA Pediatrics on July 27, 2026, enrolled 830 young children with severe early childhood tooth decay. Participants received silver diamine fluoride or placebo at enrollment and again six months later, with examinations continuing through eight months. NIH highlighted the findings on August 25. [NIH research summary](https://www.nih.gov/news-events/nih-research-matters/coating-stops-tooth-decay-children).

The primary outcome assessed individual cavities six months after one application of the 38% solution. Arrest rates were 54% with treatment and 22.5% with placebo, a difference of 31.5 percentage points. These percentages describe lesions, not children becoming cavity-free. The randomized comparison supports a treatment benefit, but uncertainty remains: only 584 children completed the study, and follow-up was relatively short. Because the comparator was placebo, these findings alone cannot establish superiority over fillings or other active treatments. [Randomized clinical trial](https://pubmed.ncbi.nlm.nih.gov/42507437/).

How does silver diamine fluoride work against tooth decay?

Tooth decay develops when acids produced by bacteria repeatedly remove minerals from teeth. Silver diamine fluoride combines antimicrobial activity with support for remineralization, helping affected tissue become harder and more resistant to continued breakdown. A clinician applies the liquid directly to the lesion. However, stopping disease activity does not rebuild the missing shape of a tooth; some teeth still need a restoration to recover function. [American Dental Association overview](https://www.ada.org/resources/ada-library/oral-health-topics/silver-diamine-fluoride).

The practical appeal is especially clear for young children who cannot easily tolerate lengthy dental procedures. The American Academy of Pediatric Dentistry supports its use within an individualized management plan and recognizes that it may prevent or delay more extensive treatment. This suggests a useful role when conventional care is difficult to provide, although any reduction in surgery or anesthesia should be measured directly rather than assumed from cavity-arrest results. [AAPD policy](https://www.aapd.org/globalassets/media/policies_guidelines/p_silverdiamine.pdf).

What should parents know before choosing this treatment?

The most visible tradeoff is permanent discoloration of the decayed tooth tissue. Although the trial involved baby teeth that will eventually fall out, appearance can still matter to children and families. NIH also reported no difference in dental pain between the groups, so improved cavity arrest should not be interpreted as demonstrated pain relief. [NIH findings](https://www.nih.gov/news-events/nih-research-matters/coating-stops-tooth-decay-children).

Regulatory clearance and clinical use also deserve distinction. The American Dental Association describes silver diamine fluoride as FDA-cleared for tooth sensitivity, with cavity-arrest treatment used off-label. A dentist should assess suitability, discuss alternatives and monitor whether lesions have stopped progressing. Repeat applications may be necessary, and a treated tooth can still require a filling or other care. The new trial adds evidence; publication itself does not confer a new FDA authorization. [ADA guidance](https://www.ada.org/resources/ada-library/oral-health-topics/silver-diamine-fluoride).